COVID Vaccines/Therapeutics – Developer/Manufacturer Announcements
[Selected press releases/announcements from organizations from WHO EUL/PQ listing above and other organizations]

 

AstraZeneca
Press Releases – No new digest announcements identified

Bharat Biotech
Press Releases
May 10: CEPI partners with consortium of Bharat Biotech, University of Sydney and ExcellGene to develop ‘variant-proof’ COVID-19 vaccine

BioCubaFarma – Cuba
Últimas Noticias – Website not leading at inquiry

 

Biological E
News – No new digest announcements identified

 

Biontech
Press Releases – No new digest announcements identified

 

CanSinoBIO
News – Website not responding at inquiry

 

CIGB
Latest News – No new digest announcements identified

 

Cinagen
Recent News – No new digest announcements identified

Clover Biopharmaceuticals – China
News – No new digest announcements identified

 

Curevac [Bayer Ag – Germany]
News – No new digest announcements identified

 

Gamaleya National Center
Latest News and Events – See Russia below.

IMBCAMS, China
Home – Website not responding at inquiry

 

Janssen/JNJ
Press Releases – No new digest announcements identified

 

Medicago
Media – No new digest announcements identified

 

Moderna
Press Releases
11 May, 2022
Departure of Jorge Gomez and Continuation of David Meline as Chief Financial Officer

 

Nanogen
News – No new digest announcements identified

 

Novavax
Press Releases
May 13, 2022
Statement – COVID-19
Novavax Files for Emergency Use Authorization of COVID-19 Vaccine in Taiwan

 

Pfizer
Recent Press Releases
05.13.2022
Pfizer and BioNTech Provide Update on COVID-19 Vaccine Supply Agreement with European Commission
…This amendment rephases planned deliveries to help support the European Commission and Member States’ ongoing immunization programs, and is aligned to the companies’ commitment to working collaboratively to identify pragmatic solutions to address the evolving pandemic needs. Doses scheduled for delivery in June through August 2022, will now be delivered in September through fourth quarter 2022. This change of delivery schedule does not impact the companies’ full-year 2022 revenue guidance or the full-year commitment of doses to be delivered to EC Member States in 2022…

 

R-Pharm
https://rpharm-us.com/index.php
[No news or media page identified]

 

Sanofi Pasteur
Press Releases
May 11 2022 Press releases
New nirsevimab data analyses reinforce efficacy against RSV
A prespecified pooled analysis of Phase 3 and Phase 2b data demonstrated an efficacy of 79.5% against medically attended lower respiratory tract infections (LRTI), including hospitalizations, caused by respiratory syncytial virus (RSV)1
Nirsevimab is the first investigational immunization designed to protect all infants across the RSV season with a single dose
Two analyses are being presented at the European Society for Paediatric Infectious Diseases meeting1,2

 

Serum Institute of India
NEWS & ANNOUNCEMENTS – No new digest announcements identified

Shifa Pharmed [Iran]
http://shafapharmed.com/
No news page identified.

 

Sinopharm/WIBPBIBP
News – No new digest announcements identified

 

Sinovac
Press Releases – No new digest announcements identified

 

Vector State Research Centre of Viralogy and Biotechnology
Home – No new digest announcements identified [404 error]

 

WestVac Biopharma
Media – No new digest announcements identified

Zhifei Longcom, China
[Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.]
[No website identified]

 

::::::

GSK
Press releases for media – No new digest announcements identified

 

Merck
News releases – No new digest announcements identified

 

Novartis
News – No new digest announcements identified

 

SK Biosciences
Press Releases – No new digest announcements identified

 

Valneva
Press Releases – No new digest announcements identified